Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.855 USD | -0.80% | +11.75% | -2.37% |
Jun. 06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
Jun. 05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.37% | 151M | |
+45.86% | 754B | |
+40.95% | 630B | |
-5.61% | 352B | |
+19.89% | 331B | |
+9.38% | 298B | |
+18.45% | 250B | |
+11.88% | 217B | |
-0.78% | 216B | |
+6.61% | 164B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- I Mab : Cantor Fitzgerald Adjusts I-Mab's Price Target to $90 From $76, Maintains Overweight Rating